The new standard of HCV therapy: Treatment in therapy‐naive patients
Saurabh Agrawal, Paul Y. Kwo – 6 March 2012 – Watch the interview with the authors
The long‐term horizon: Patients who will remain untreated in the era of triple therapy
Andrew Aronsohn, Donald Jensen – 6 March 2012 – Watch the interview with the authors
The new standard of HCV therapy: Treatment in therapy‐naive patients
Saurabh Agrawal, Paul Y. Kwo – 6 March 2012 – Watch the interview with the authors
The new standard of HCV therapy: Retreatment in experienced patients
Naveen Gara, Marc G. Ghany – 6 March 2012 – Watch the interview with the authors
A brief history of the treatment of viral hepatitis C
Doris B. Strader, Leonard B. Seeff – 6 March 2012 – Watch the interview with the authors
The long‐term horizon: Patients who will remain untreated in the era of triple therapy
Andrew Aronsohn, Donald Jensen – 6 March 2012 – Watch the interview with the authors
A brief history of the treatment of viral hepatitis C
Doris B. Strader, Leonard B. Seeff – 6 March 2012 – Watch the interview with the authors
The new standard of HCV therapy: Retreatment in experienced patients
Naveen Gara, Marc G. Ghany – 6 March 2012 – Watch the interview with the authors
The horizon: New targets and new agents
Alison B. Jazwinski, Andrew J. Muir – 6 March 2012 – Watch the interview with the authors
Can we cure cholangiocarcinoma with neoadjuvant chemoradiation and liver transplantation? Time for a multicenter trial
Robin K. Kelley, Ryutaro Hirose, Alan P. Venook – 5 March 2012